---
title: "Edwards Lifesciences Corporation Stock 12‑Month Price Target Raised to $101.57, Implies 21% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293783660.md"
description: "Edwards Lifesciences Corporation's average 12-month price target has been raised to $100.98 by 24 analysts, up from $100.03, implying a 20% upside based on the July 23 closing price. The consensus rating remains 'Buy' among 30 covering analysts, with 22 buys, 8 holds, and no sells."
datetime: "2026-07-24T17:20:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293783660.md)
  - [en](https://longbridge.com/en/news/293783660.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293783660.md)
generator: "portal-rs"
---

# Edwards Lifesciences Corporation Stock 12‑Month Price Target Raised to $101.57, Implies 21% Upside

-   According to estimates from 24 analysts, Edwards Lifesciences Corporation stock's average price target has risen from $100.03 to $100.98, with forecasts ranging from $85 to $110 per share
-   Based on the Jul. 23 closing price, the updated target implies approximately 20% potential upside
-   Consensus rating remains at “Buy” across 30 covering analysts, with 22 Buys, 8 Holds and 0 Sells

Explore more price target data and ratings for Edwards Lifesciences Corporation on the , and track all previous and future analyst recommendations for Edwards Lifesciences Corporation in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [EW.US](https://longbridge.com/en/quote/EW.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [15:32 ETDid Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?](https://longbridge.com/en/news/298231443.md)
- [Edwards Lifesciences CVP, TAVR Daniel J. Lippis disposes of 619 common shares worth $54,168.69](https://longbridge.com/en/news/298775671.md)
- [Edwards Lifesciences Comments on TAVR National Coverage Decision | EW Stock News](https://longbridge.com/en/news/298649035.md)
- [$100 oil: A round number problem for a multi-sided market](https://longbridge.com/en/news/298480401.md)
- [What smart people are saying about oil prices surging back toward $100](https://longbridge.com/en/news/298342221.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**